These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 39019021)

  • 1. A Non-Interventional, Multicenter Study to Characterize the Socio-Demographics, Clinical Characteristics, and Management of Generalized Pustular Psoriasis Patients in Spain: IMPULSE Study.
    Puig L; Izu Belloso R; Rivera-Díaz R; Mollet Sánchez J; Rodríguez Fernández-Freire L; Sahuquillo-Torralba A; Ruiz-Villaverde R;
    Dermatology; 2024 Jul; ():1-15. PubMed ID: 39019021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design of Effisayil™ 2: A Randomized, Double-Blind, Placebo-Controlled Study of Spesolimab in Preventing Flares in Patients with Generalized Pustular Psoriasis.
    Morita A; Choon SE; Bachelez H; Anadkat MJ; Marrakchi S; Zheng M; Tsai TF; Turki H; Hua H; Rajeswari S; Thoma C; Burden AD
    Dermatol Ther (Heidelb); 2023 Jan; 13(1):347-359. PubMed ID: 36333618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current Treatments for Generalized Pustular Psoriasis: A Narrative Summary of a Systematic Literature Search.
    Puig L; Fujita H; Thaçi D; Zheng M; Hernandez Daly AC; Leonardi C; Lebwohl MG; Barker J
    Dermatol Ther (Heidelb); 2024 Sep; 14(9):2331-2378. PubMed ID: 39088126
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spesolimab for generalized pustular psoriasis: a review of two key clinical trials supporting initial US regulatory approval.
    Gwillim EC; Nichols AJ
    Front Immunol; 2024; 15():1359481. PubMed ID: 39104539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful treatment of acrodermatitis continua of Hallopeau coexisting with generalized pustular psoriasis with spesolimab: a case report.
    Wen P; Liu C; Wang T; Jiang X; Wang P; Wang S
    Front Immunol; 2024; 15():1338285. PubMed ID: 38464535
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of Biological Therapies for the Management of Pustular Psoriasis: A New Era?
    Megna M; Camela E; Ruggiero A; Battista T; Martora F; Cacciapuoti S; Potestio L
    Clin Cosmet Investig Dermatol; 2023; 16():1677-1690. PubMed ID: 37404368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of the interleukin-36 axis in generalized pustular psoriasis: a review of the mechanism of action of spesolimab.
    Hawkes JE; Visvanathan S; Krueger JG
    Front Immunol; 2023; 14():1292941. PubMed ID: 38077370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exploring the Quality-of-Life Impact, Disease Burden, and Management Challenges of GPP: The Provider and Patient Perspective [Podcast].
    Hawkes JE; Reisner DV; Bhutani T
    Clin Cosmet Investig Dermatol; 2023; 16():3333-3339. PubMed ID: 38021429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effective Management of Life-Threatening Generalized Pustular Psoriasis Flare With Spesolimab.
    Zafiriou E; Karampinis E; Giannoulis G; Gravani A; Gampeta S; Zachou K
    Cureus; 2024 Jul; 16(7):e64474. PubMed ID: 39135818
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generalized Pustular Psoriasis: A Review on Clinical Characteristics, Diagnosis, and Treatment.
    Rivera-Díaz R; Daudén E; Carrascosa JM; Cueva P; Puig L
    Dermatol Ther (Heidelb); 2023 Mar; 13(3):673-688. PubMed ID: 36635445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Course and Characteristics of Generalized Pustular Psoriasis.
    Choon SE; Navarini AA; Pinter A
    Am J Clin Dermatol; 2022 Jan; 23(Suppl 1):21-29. PubMed ID: 35061227
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pustular Psoriasis: A Narrative Review of Recent Developments in Pathophysiology and Therapeutic Options.
    Menter A; Van Voorhees AS; Hsu S
    Dermatol Ther (Heidelb); 2021 Dec; 11(6):1917-1929. PubMed ID: 34626330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical Characteristics and Outcomes of Generalized Pustular Psoriasis Flares.
    Choon SE; Lebwohl MG; Turki H; Zheng M; Burden AD; Li L; Quaresma M; Thoma C; Bachelez H
    Dermatology; 2023; 239(3):345-354. PubMed ID: 36796336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical Characteristics and Disease Burden of Patients with Moderate-to-Severe Generalized Pustular Psoriasis Flares in Taiwan.
    Lu CW; Tseng CY; Wang CW; Lin SH; Chen CB; Hui RC; Chi CC; Huang YH; Lee CH; Lin FJ; Chung WH
    Dermatol Ther (Heidelb); 2024 Aug; 14(8):2261-2275. PubMed ID: 39078583
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characteristics and management of generalized pustular psoriasis (GPP): Experience from the Central and Eastern Europe (CEE) GPP Expert Network.
    Wolf P; Ceovic R; Conrad C; Falkensteiner K; Graier T; Kołt-Kamińska M; Marovt M; Mateeva V; Maul JT; Navarini AA; Nicolescu AC; Ratzinger G; Pavlovsky L; Sanzharovskaya M; Szegedi A; Reich A
    J Eur Acad Dermatol Venereol; 2024 Aug; 38(8):1531-1542. PubMed ID: 38279888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of spesolimab for the management of generalized pustular psoriasis: a drug safety evaluation.
    Potestio L; Camela E; Cacciapuoti S; Martora F; Guerriero L; Fornaro L; Ruggiero A; Megna M
    Expert Opin Drug Saf; 2023; 22(11):1003-1010. PubMed ID: 37768729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spesolimab for the Treatment of Generalized Pustular Psoriasis.
    Bernardo D; Thaçi D; Torres T
    Drugs; 2024 Jan; 84(1):45-58. PubMed ID: 38114719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generalized pustular psoriasis: practical recommendations for Spanish primary care and emergency physicians.
    Rivera-Diaz R; Epelde F; Heras-Hitos JA; Martínez Virto AM; Dávalos Marin AJ; Senán Sanz MR; Carrascosa JM
    Postgrad Med; 2023 Nov; 135(8):766-774. PubMed ID: 38019177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exploring the Clinical Assessment, Guidelines, and Options for the Treatment of Generalized Pustular Psoriasis [Podcast].
    Song EJ; Liu C
    Clin Cosmet Investig Dermatol; 2023; 16():2911-2917. PubMed ID: 37915421
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Study protocol of the global Effisayil 1 Phase II, multicentre, randomised, double-blind, placebo-controlled trial of spesolimab in patients with generalized pustular psoriasis presenting with an acute flare.
    Choon SE; Lebwohl MG; Marrakchi S; Burden AD; Tsai TF; Morita A; Navarini AA; Zheng M; Xu J; Turki H; Rajeswari S; Deng H; Tetzlaff K; Thoma C; Bachelez H
    BMJ Open; 2021 Mar; 11(3):e043666. PubMed ID: 33785490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.